BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10327141)

  • 1. Urinary screening tests for fetal Down syndrome: II. Hyperglycosylated hCG.
    Cole LA; Shahabi S; Oz UA; Rinne KM; Omrani A; Bahado-Singh RO; Mahoney MJ
    Prenat Diagn; 1999 Apr; 19(4):351-9. PubMed ID: 10327141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
    Spencer K; Aitken DA; Macri JN; Buchanan PD
    Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
    Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
    Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second trimester maternal serum pregnancy specific beta-1 glycoprotein (SP-1) levels in normal and Down syndrome pregnancies.
    Petrocik E; Wassman ER; Lee JJ; Kelly JC
    Am J Med Genet; 1990 Sep; 37(1):114-8. PubMed ID: 2146876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary beta-core hCG: screening for aneuploidies in early pregnancy (11-14 weeks' gestation).
    Macintosh MC; Nicolaides KH; Noble P; Chard T; Gunn L; Iles R
    Prenat Diagn; 1997 May; 17(5):401-5. PubMed ID: 9178313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for Down syndrome pregnancy using beta-core fragment: prospective study.
    Isozaki T; Palomaki GE; Bahado-Singh RO; Cole LA
    Prenat Diagn; 1997 May; 17(5):407-13. PubMed ID: 9178314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 12 assays for detecting hCG and related molecules in urine samples from Down syndrome pregnancies.
    Cole LA; Kellner LH; Isozaki T; Palomaki GE; Iles RK; Walker RP; Ozaki M; Canick JA
    Prenat Diagn; 1997 Jul; 17(7):607-14. PubMed ID: 9249860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple marker screening for Down syndrome in twin pregnancies.
    Neveux LM; Palomaki GE; Knight GJ; Haddow JE
    Prenat Diagn; 1996 Jan; 16(1):29-34. PubMed ID: 8821849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal urinary beta-core fragment of hCG/creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy.
    Hayashi M; Kozu H
    Prenat Diagn; 1995 Jan; 15(1):11-6. PubMed ID: 7537878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-trimester maternal serum CA-125 versus estriol in the multiple-marker screening test for Down syndrome.
    Wenstrom KD; Owen J; Boots L
    Obstet Gynecol; 1997 Mar; 89(3):359-63. PubMed ID: 9052585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum inhibin-A in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome.
    Wald NJ; Watt HC; George L
    Prenat Diagn; 1996 Oct; 16(10):923-6. PubMed ID: 8938061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal diagnosis of a deletion of 18q in a fetus associated with multiple-marker screen positive results.
    Chen CP; Chern SR; Liu FF; Jan SW; Lee CC; Chang YC; Yue CT
    Prenat Diagn; 1997 Jun; 17(6):571-6. PubMed ID: 9203216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-trimester levels of maternal urinary gonadotropin peptide in Down syndrome pregnancy.
    Canick JA; Kellner LH; Saller DN; Palomaki GE; Walker RP; Osathanondh R
    Prenat Diagn; 1995 Aug; 15(8):739-44. PubMed ID: 7479592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary beta-core human chorionic gonadotrophin: a new approach to Down's syndrome screening.
    Cuckle HS; Iles RK; Chard T
    Prenat Diagn; 1994 Oct; 14(10):953-8. PubMed ID: 7534925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal serum hCG and SP1 in pregnancies with fetal aneuploidy.
    Bartels I; Thiele M; Bogart MH
    Am J Med Genet; 1990 Oct; 37(2):261-4. PubMed ID: 2147362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Criteria for fetal nuchal thickness cut-off: a re-evaluation.
    Borrell A; Costa D; Martinez JM; Delgado RD; Farguell T; Fortuny A
    Prenat Diagn; 1997 Jan; 17(1):23-9. PubMed ID: 9021825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary multiple marker screening for Down's syndrome.
    Cuckle HS; Iles RK; Sehmi IK; Chard T; Oakey RE; Davies S; Ind T
    Prenat Diagn; 1995 Aug; 15(8):745-51. PubMed ID: 7479593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome.
    Macri JN; Spencer K; Garver K; Buchanan PD; Say B; Carpenter NJ; Muller F; Boué A
    Prenat Diagn; 1994 Feb; 14(2):97-103. PubMed ID: 7514291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New, simple and sensitive urinary and blood pregnancy tests. A market study with special reference to the diagnosis of extra-uterine pregnancies].
    Daae LN; Jerve F; Torjesen P
    Tidsskr Nor Laegeforen; 1987 Mar; 107(7):656-8. PubMed ID: 3576561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities.
    Bogart MH; Pandian MR; Jones OW
    Prenat Diagn; 1987 Nov; 7(9):623-30. PubMed ID: 2447576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.